Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer

被引:0
作者
Michael L Maitland
Matthew R Levine
Mario E Lacouture
Kristen E Wroblewski
Christine H Chung
Ilyssa O Gordon
Livia Szeto
Gail Ratko
Keyoumars Soltani
Mark F Kozloff
Philip C Hoffman
Ravi Salgia
David P Carbone
Theodore G Karrison
Everett E Vokes
机构
[1] University of Chicago,Department of Health Studies
[2] Section of Hematology/Oncology,Department of Pathology
[3] University of Chicago,undefined
[4] Section of Dermatology,undefined
[5] University of Chicago,undefined
[6] Committee on Clinical Pharmacology and Pharmacogenomics,undefined
[7] University of Chicago,undefined
[8] Comprehensive Cancer Center,undefined
[9] University of Chicago,undefined
[10] University of Chicago,undefined
[11] Memorial Sloan-Kettering Cancer Center,undefined
[12] Johns Hopkins University,undefined
[13] Kimmel Cancer Center,undefined
[14] Vanderbilt University Medical Center,undefined
[15] Ingalls Hospital,undefined
[16] One Ingalls Dr,undefined
来源
BMC Cancer | / 14卷
关键词
Pemetrexed; Lung Cancer; Cetuximab; Rash; EGFR; Proteomics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 229 条
[31]  
Harbison CT(2007)Phase I/II study of cetuximab dose-escalation in patients with metastatic colorectal cancer (mCRC) with no or slight skin reactions on cetuximab standard dose treatment (EVEREST): Pharmacokinetic (PK), Pharmacodynamic (PD) and efficacy data ASCO Meet Abstr 25 4037-undefined
[32]  
Hart LL(2008)Validation of treatment induced specific adverse effect as a predictor of treatment benefit: a case study of NCIC CTG BR21 Contemp clin trials 29 527-undefined
[33]  
Awad M(2010)Analysis of the yield of phase II combination therapy trials in medical oncology Clin Cancer Res 16 5296-undefined
[34]  
Xu LA(undefined)undefined undefined undefined undefined-undefined
[35]  
Horak CE(undefined)undefined undefined undefined undefined-undefined
[36]  
Dakhil S(undefined)undefined undefined undefined undefined-undefined
[37]  
Hermann RC(undefined)undefined undefined undefined undefined-undefined
[38]  
Lynch TJ(undefined)undefined undefined undefined undefined-undefined
[39]  
Weber MR(undefined)undefined undefined undefined undefined-undefined
[40]  
O'Byrne KJ(undefined)undefined undefined undefined undefined-undefined